Simple bi- and tricyclic inhibitors of human steroid 5α-reductase

被引:11
作者
Abell, AD [1 ]
Prince, MJ
McNulty, AM
Neubauer, BL
机构
[1] Univ Canterbury, Dept Chem, Christchurch 1, New Zealand
[2] Lilly Res Labs, Indianapolis, IN 46285 USA
关键词
D O I
10.1016/S0960-894X(00)00368-1
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A number of tricyclic thiolactams, bicyclic lactams, and bicyclic thiolactams have been prepared and evaluated in vitro as inhibitors of types and ? steroid 5 alpha-reductase. The tricycles with an 8-chloro substituent in the C-ring are nM (IC50) inhibitors of type steroid 5 alpha-reductase (SR). In all the cases studied, lactams are more potent than the corresponding thiolactams. Activity against type 2 SR is greatly enhanced by a styryl (or ate) substituent on the aryl ring of the tri- and bicycles and also a related tricyclic aryl acid. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1909 / 1911
页数:3
相关论文
共 19 条
[1]   PREPARATIVE CHIRAL HPLC SEPARATION OF ALL POSSIBLE STEREOISOMERS OF LY191704 AND LY266111 AND THEIR IN-VITRO INHIBITION OF HUMAN TYPE-1 AND TYPE-2 STEROID 5-ALPHA-REDUCTASES [J].
ABELL, AD ;
ERHARD, KF ;
YEN, HK ;
YAMASHITA, DS ;
BRANDT, M ;
MOHAMMED, H ;
LEVY, MA ;
HOLT, DA .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (11) :1365-1368
[2]  
ABELL AD, 1995, CURR MED CHEM, V2, P583
[3]   A comparison of steroidal and non-steroidal inhibitors of human steroid 5 alpha-reductase: New tricyclic aryl acid inhibitors of the type-1 isozyme [J].
Abell, AD ;
Brandt, M ;
Levy, MA ;
Holt, DA .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (04) :481-484
[4]  
DIANI AR, 1992, J CLIN ENDOCR METAB, V74, P505
[5]   STEROIDAL A-RING ARYL CARBOXYLIC-ACIDS - A NEW CLASS OF STEROID 5-ALPHA-REDUCTASE INHIBITORS [J].
HOLT, DA ;
LEVY, MA ;
LADD, DL ;
OH, HJ ;
ERB, JM ;
HEASLIP, JI ;
BRANDT, M ;
METCALF, BW .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (03) :937-942
[6]   BENZOPHENONECARBOXYLIC AND INDOLECARBOXYLIC ACIDS - POTENT TYPE-2 SPECIFIC INHIBITORS OF HUMAN STEROID 5-ALPHA-REDUCTASE [J].
HOLT, DA ;
YAMASHITA, DS ;
KONIALIANBECK, AL ;
LUENGO, JI ;
ABELL, AD ;
BERGSMA, DJ ;
BRANDT, M ;
LEVY, MA .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (01) :13-15
[7]  
HOLT KG, 1993, PHYS THER PRACT, V2, P1
[8]   GENETIC AND PHARMACOLOGICAL EVIDENCE FOR MORE THAN ONE HUMAN STEROID 5-ALPHA-REDUCTASE [J].
JENKINS, EP ;
ANDERSSON, S ;
IMPERATOMCGINLEY, J ;
WILSON, JD ;
RUSSELL, DW .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (01) :293-300
[9]   NONSTEROIDAL INHIBITORS OF HUMAN TYPE-I STEROID 5-ALPHA-REDUCTASE [J].
JONES, CD ;
AUDIA, JE ;
LAWHORN, DE ;
MCQUAID, LA ;
NEUBAUER, BL ;
PIKE, AJ ;
PENNINGTON, PA ;
STAMM, NB ;
TOOMEY, RE ;
HIRSCH, KS .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (03) :421-423
[10]  
JULIA M, 1968, J B SOC CHIM FR, V3, P1000